Biopharma is a relatively small sector of the markets, but a much larger share of new equity issuances – and it’s been growing in size. It’s now the largest subsector in the Russell 2000
Biopharma is a relatively small sector of the markets, but a much larger share of new equity issuances – and it’s been growing in size. It’s now the largest subsector in the Russell 2000